Searchable abstracts of presentations at key conferences in endocrinology

ea0081p656 | Pituitary and Neuroendocrinology | ECE2022

Insulin resistance, glucose and lipid metabolism in patients with PROP 1 mutation –single center, long term observation

Kluczyński Łukasz , Partyński Bartosz , Rogoziński Damian , Bogusławska Anna , Zygmunt-Gorska Agata , Wojcik Małgorzata , Starzyk Jerzy , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: A mutation in the PROP-1 gene is a rare cause of childhood-onset hypopituitarism. Patients with the disorder usually present with multiple pituitary hormone deficits. The pattern of development and the course of insufficiencies of individual axes remain unclear and affect patients metabolic status. Growth hormone therapy and substitution of other hormones may influence on glucose and lipid metabolism as well. Aim: To characterize the carboh...

ea0090p778 | Thyroid | ECE2023

Severe post-amiodarone thyrotoxicosis: personalized approach for radical treatment in a life-threatening condition

Opalinska Marta , Pantoflinski Jacek , Sokołowski Grzegorz , Pach Dorota , Kostecka-Matyja Marta , Żabicka Katarzyna , Partyński Bartosz , Kieć-Klimczak Małgorzata , Sowa-Staszczak Anna , Buziak-Bereza Monika , Gilis-Januszewska Aleksandra , Hubalewska-Dydejczyk Alicja

Background: Despite increased awareness among cardiologists about the risk of amiodarone’s significant side effects, it is still a commonly used antiarrhythmic drug. Amiodarone may induced easy for management hypothyroidism which affect even 25% of patients or less frequent thyrotoxicosis (AIT) which causes a challenge for clinicians. Type 1 of AIT occurs on the basis of pre-existing thyroid diseases such as nodular goiter or latent Graves’ disease, type 2 results fr...